Status:
COMPLETED
Probiotics in Respiratory Tract Infections in Children
Lead Sponsor:
Lviv National Medical University
Conditions:
Infections, Respiratory Tract
Eligibility:
All Genders
3-12 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the potential of probiotics in prevention of respiratory tract infections and their complications in children
Eligibility Criteria
Inclusion
- Age 3-12 yrs
- At least one episode of respiratory tract infection in the previous epidemiological season
- Direct telephone access available
- Informed consent signed
Exclusion
- Vaccination against the influenza
- Chronic adeno-tonsillar pathology
- Recurrent otitis
- Sinusitis
- Respiratory allergy
- Acute or chronic intestinal disease with diarrhea and/or malabsorption syndrome
- Lactose intolerance
- Functional or organic constipation
- Down syndrome
- Congenital or acquired heart disease
- Cerebral palsy
- Any chronic hepatic, renal, metabolic, or immune system disease
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT01510938
Start Date
January 1 2012
End Date
December 1 2012
Last Update
December 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lviv City Children Hospital
Lviv, Lviv Oblast, Ukraine, 79059